Brief: Kinnate Biopharma Q3 Basic EPS USD -0.65
09/11/2023 21:05
Nov 09 (Reuters) - Kinnate Biopharma Q3 operating income USD -33.089 million. * Q3 net income USD -30.733 million * Q3 operating expenses USD 33.089 million
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview